Karuna Therapeutics, Inc. (KRTX) Social Stream
KARUNA THERAPEUTICS INC (KRTX) Price Targets From Analysts
Use the tables below to see what analysts covering KARUNA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 12 | $185 | $152 | $171.6 | $229.26 | -25.15% |
| 2022-01-03 | 12 | $185 | $152 | $171.636 | $229.26 | -25.13% |
| 2022-01-13 | 13 | $185 | $150 | $169.833 | $229.26 | -25.92% |
| 2022-01-24 | 13 | $185 | $150 | $170.583 | $229.26 | -25.59% |
| 2022-02-25 | 12 | $185 | $150 | $170.583 | $229.26 | -25.59% |
| 2022-03-08 | 10 | $185 | $150 | $171.09 | $229.26 | -25.37% |
| 2022-03-22 | 10 | $185 | $150 | $169.818 | $229.26 | -25.93% |
| 2022-03-28 | 10 | $185 | $150 | $171 | $229.26 | -25.41% |
| 2022-04-14 | 11 | $190 | $150 | $172.583 | $229.26 | -24.72% |
| 2022-04-27 | 10 | $190 | $150 | $173.25 | $229.26 | -24.43% |
| 2022-05-06 | 11 | $190 | $150 | $173.666 | $229.26 | -24.25% |
| 2022-05-25 | 12 | $190 | $150 | $172.583 | $229.26 | -24.72% |
| 2022-06-12 | 12 | $190 | $150 | $172.692 | $229.26 | -24.67% |
| 2022-07-26 | 14 | $190 | $150 | $172.25 | $229.26 | -24.87% |
| 2022-08-02 | 14 | $190 | $150 | $172.461 | $229.26 | -24.77% |
| 2022-08-09 | 16 | $315 | $150 | $230.357 | $229.26 | 0.48% |
| 2022-08-11 | 18 | $315 | $150 | $246.866 | $229.26 | 7.68% |
| 2022-08-13 | 18 | $330 | $150 | $254.411 | $229.26 | 10.97% |
| 2022-08-15 | 18 | $330 | $150 | $263.823 | $229.26 | 15.08% |
| 2022-08-18 | 18 | $330 | $150 | $266.294 | $229.26 | 16.15% |
| 2022-08-19 | 17 | $330 | $175 | $275.117 | $229.26 | 20% |
| 2022-09-17 | 17 | $330 | $175 | $277.176 | $229.26 | 20.9% |
| 2022-10-13 | 17 | $330 | $175 | $277.235 | $229.26 | 20.93% |
| 2022-11-03 | 18 | $330 | $175 | $277.833 | $229.26 | 21.19% |
| 2022-11-08 | 18 | $330 | $175 | $277.555 | $229.26 | 21.07% |
| 2022-12-06 | 18 | $330 | $190 | $283.277 | $229.26 | 23.56% |
| 2023-01-03 | 18 | $330 | $190 | $282.944 | $229.26 | 23.42% |
| 2023-01-05 | 19 | $330 | $190 | $283.052 | $229.26 | 23.46% |
| 2023-01-27 | 20 | $330 | $190 | $283.157 | $229.26 | 23.51% |
| 2023-02-15 | 20 | $330 | $190 | $279.45 | $229.26 | 21.89% |
| 2023-02-24 | 20 | $330 | $190 | $279.4 | $229.26 | 21.87% |
| 2023-03-03 | 20 | $330 | $190 | $276.9 | $229.26 | 20.78% |
| 2023-03-21 | 21 | $330 | $190 | $274.285 | $229.26 | 19.64% |
| 2023-03-23 | 21 | $330 | $190 | $273.904 | $229.26 | 19.47% |
| 2023-03-28 | 21 | $330 | $190 | $272.952 | $229.26 | 19.06% |
| 2023-05-04 | 20 | $330 | $209 | $277.1 | $229.26 | 20.87% |
| 2023-05-08 | 21 | $330 | $209 | $272.35 | $229.26 | 18.8% |
The Trend in the Analyst Price Target
Over the past 26 weeks, KRTX's average price target has gone down $5.2.
KRTX reports an average of 33.92% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-17 | 17 | 330 | 175 | 277.176 | 239.35 | 15.8% |
| 2023-01-03 | 18 | 330 | 190 | 282.944 | 193.19 | 46.46% |
| 2023-01-23 | 19 | 330 | 190 | 283.157 | 196.50 | 44.1% |
| 2023-01-31 | 20 | 330 | 190 | 279.450 | 199.39 | 40.15% |
| 2023-03-21 | 21 | 330 | 190 | 274.285 | 161.33 | 70.01% |
KRTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.24 | 18 | 1 | 2 | 0 | 0 | 21 |
The Trend in the Broker Recommendations
KRTX's average broker recommendation rating worsened by 0.25 over the prior 13 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- KARUNA THERAPEUTICS INC's average analyst price target is higher than 4557.67% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, KARUNA THERAPEUTICS INC's number of analysts covering the stock is greater than 4671.61% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, KARUNA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 595.56% of them.
- KARUNA THERAPEUTICS INC's variance in analysts' estimates is lower than -1267.86% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, STOK, NBRV, and PTGX are the three stocks most similar to KARUNA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is KRTX a Buy, Hold or Sell? See the POWR Ratings now!